Global Pazopanib Tenders and GPN from across the Globe

Amgros 2026 1.1454.B

Open House Drug Discount Agreements Pazopanib, Atc L01ex03

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Pazopanib, Atc L01ex03 for the Period January 1St, 2026 - December 31St, 2027 (Plus Extension Option 1X12 Months)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Pazopanib, Atc L01ex03 for the Period January 1St, 2026 - December 31St, 2027 (Plus Extension Option 1X12 Months)

Supply of Pazopanib 200Mg Tablet Qty 1000, Cefoperazone -Sulbactum 1.5Gm Injection Qty 21880 at Bathinda

Pazopanib / Pazopanib, Eltrombopag / Eltrombopag under Code Dk 021:2015: 33600000-6 — Pharmaceutical Products

Supply of the Drug Pazopanib as Part of Preferential Drug Coverage (Onco). (P25-01-5078)

Corrigendum: Tab Pazopanib 400mg, Qty: 500 Tab, (BOQ Item #13)

Registration of Drug Prices, in Compliance with a Court Order. Note: in Case of Discrepancy between the Description in Annex Ii and that of the Purchasing System, the Provisions in Annex Ii of the Notice will Prevail.

Drug Discount Agreements from January 1St, 2026 on Various Active Ingredients as Part of an Open House Procedure